Sensei Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary

Faeth Therapeutics,

04/08/2021 14:48

* Sensei Biotherapeutics Inc  SNSE.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 29 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Sensei Biotherapeutics Inc's reported EPS for the quarter was
a loss of 32 cents​.
* The mean earnings estimate of analysts had risen by about 4.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sensei Biotherapeutics Inc shares had fallen by 23.7% this
quarter.
* The company reported a quarterly loss of $9.71 million.
* Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $12.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 4 at 01:48 p.m.  ​All
figures in US dollars unless otherwise stated